Together, these data suggest that COMP-expressing fibroblasts expand post-treatment and accumulate in pauci-cellular niches over time, providing a first indication of active fibrogenic remodeling in the fibroblast-rich compartment of RA. The gene discussed is COMP; the disease is rheumatoid arthritis.